C. Cordonnier

发表

Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT

A. Zander, M. Labopin, J. Finke, 2009, Bone Marrow Transplantation.

Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms.

M. Vidaud, C. Cordonnier, M. Goossens, 1987, Blood.

PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma.

E. Itti, C. Cordonnier, D. Bories, 2006, Haematologica.

Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients

S. Sorensen, C. Solano, D. Vanness, 2015, BMC Infectious Diseases.

Real-Time PCR Coupled with Automated DNA Extraction and Detection of Galactomannan Antigen in Serum by Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis

C. Cordonnier, C. Desterke, F. Botterel, 2002, Journal of Clinical Microbiology.

Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis.

C. Rieux, C. Cordonnier, J. M. Costa, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients.

P. Ljungman, R. Martino, C. Cordonnier, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts.

J. Bernaudin, A. Lassence, C. Cordonnier, 1995, American journal of respiratory and critical care medicine.

Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study

W. Gruber, P. Ljungman, C. Cordonnier, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Secondary alveolar proteinosis in cancer patients

J. Bernaudin, J. Nhieu, C. Cordonnier, 1996, Supportive Care in Cancer.

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT

H. Einsele, P. Ljungman, C. Cordonnier, 2008, Bone Marrow Transplantation.

Real-world issues and potential solutions in HCT during the COVID-19 pandemic: Perspectives from the WBMT and the CIBMTR's Health Services and International Studies Committee

W. Wood, N. Kröger, M. Perales, 2020, Biology of Blood and Marrow Transplantation.

Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc.

C. Rieux, O. Reman, C. Cordonnier, 1998, Transplantation.

ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients.

L. Pagano, C. Cordonnier, J. Helweg-Larsen, 2016, The Journal of antimicrobial chemotherapy.

ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

H. Einsele, P. Hauser, W. Melchers, 2016, The Journal of antimicrobial chemotherapy.

Empiric therapy of bacterial infections in severe neutropenia

J. Palmblad, M. Boogaerts, C. Cordonnier, 1997 .

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group.

R Sylvester, L Collette, L. Collette, 1998, The Journal of infection.

Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients

A. Thiébaut, U. Flückiger, C. Cordonnier, 2007 .

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.

C. Cordonnier, R. Herbrecht, N. Milpied, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acquired autoimmune thrombocytopenia after allogeneic bone marrow transplantation

P. Bierling, J. Tanzer, C. Cordonnier, 1985, British journal of haematology.

Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)

D. Livermore, I. Gyssens, C. Viscoli, 2013, Haematologica.

Toxoplasmosis after hematopoietic stem cell transplantation.

E. Deconinck, R. Martino, C. Cordonnier, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

O. Lortholary, C. Cordonnier, S. Bastuji‐Garin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Infections in myelodysplastic syndromes

P. Fenaux, C. Cordonnier, F. Dreyfus, 2012, Haematologica.

De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome

M. Venditti, C. Cordonnier, W. Akrout, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia.

T. Franquet, H. Einsele, L. Pagano, 2022, The Lancet. Infectious diseases.

Sepsis associated with immunosuppressive medications: An evidence-based review

S. Opal, J. Carcillo, K. Sepkowitz, 2004, Critical care medicine.

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)

H. Einsele, F. Baldanti, L. Pagano, 2022, Leukemia.

Mucormycosis: a new concern in the transplant ward?

C. Cordonnier, A. Alanio, C. Robin, 2014, Current opinion in hematology.

Treatment and timing in invasive mould disease.

C. Cordonnier, E. Roilides, A. Groll, 2011, The Journal of antimicrobial chemotherapy.

Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study

F. Roudot-thoraval, D. Klatzmann, G. Socié, 2014, Leukemia.

Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia

I. Durand-zaleski, H. Esperou, C. Cordonnier, 2005, Bone Marrow Transplantation.

Maury Hematopoietic Stem Cell Transplantation Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Regulatory T Cell Depletion Improves the + CD 25 + CD 4

F. Roudot-thoraval, D. Klatzmann, C. Badoual, 2010 .

CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation

F. Roudot-thoraval, D. Klatzmann, C. Badoual, 2010, Science Translational Medicine.

Searching for factors to improve the antileukemic effect of donor lymphocyte infusion.

D. Klatzmann, C. Cordonnier, J. Cohen, 2008, Blood.

The EHA Research Roadmap: Infections in Hematology

H. Einsele, A. Gennery, P. Ljungman, 2021, HemaSphere.

Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients.

J. Bernaudin, C. Cordonnier, E. Escudier, 1994, American journal of respiratory and critical care medicine.

European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia

D. Livermore, I. Gyssens, C. Viscoli, 2013, Haematologica.

Granulocyte–macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

H. Dombret, A. Vekhoff, P. Cony-Makhoul, 1999, Leukemia.

Timed sequential chemotherapy for advanced acute myeloid leukemia.

H. Dombret, P. Cony-Makhoul, H. Tilly, 1996, Hematology and cell therapy.

Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission.

J. Reiffers, G. Marit, C. Cordonnier, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission

S. Lemerle, C. Cordonnier, F. Bernaudin, 1989, Cancer.

Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cells

M. Delaforge, C. Cordonnier, O. Puel, 2007, BMC Microbiology.

ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients

H. Einsele, L. Pagano, M. Aljurf, 2017, The Journal of antimicrobial chemotherapy.

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

H. Einsele, P. Ljungman, C. Cordonnier, 2009, Bone Marrow Transplantation.

The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis.

J. Löffler, P. White, C. Cordonnier, 2020, The Journal of antimicrobial chemotherapy.

Antifungal pre-emptive strategy for high-risk neutropenic patients: why the story is still ongoing.

C. Cordonnier, S. Bretagne, A. Alanio, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients.

J. Latgé, C. Cordonnier, S. Bretagne, 1997, The Journal of infection.

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation

N. Kröger, A. Zander, R. Brand, 2009, Haematologica.

Immunization in cancer patients: where we stand.

C. Cordonnier, C. Robin, F. Beckerich, 2015, Pharmacological research.

High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs

C. Rieux, P. Bierling, C. Cordonnier, 2001, Bone Marrow Transplantation.

Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation

M. Aljurf, S. Santarone, R. Martino, 2013, Bone Marrow Transplantation.

European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL‐4 (2011)

Peter Shaw, P. Ljungman, C. Cordonnier, 2012, Transplant infectious disease : an official journal of the Transplantation Society.

Lack of Evidence of Heterozygosity for Cystic Fibrosis as a Risk Factor for Invasive Aspergillosis in Haematological Patients

E. Girodon, C. Cordonnier, S. Bretagne, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Direct vascular actions of methyclothiazide in remodeled mesenteric arteries from hypertensive patients.

M. Safar, T. Collin, M. Slama, 2001, American journal of hypertension.

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantati

H. Einsele, G. Mufti, A. Hunter, 2006, Blood.

Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

J. Bourhis, H. Dombret, B. Quesnel, 2007, Leukemia.

Donor Regulatory T Cells Identified by FoxP3 Expression but Also by the Membranous CD4+CD127low/neg Phenotype Influence Graft-versus-tumor Effect After Donor Lymphocyte Infusion

Y. Hamel, C. Cordonnier, C. Pautas, 2008, Journal of immunotherapy.

Azole Preexposure Affects the Aspergillus fumigatus Population in Patients

S. Brisse, C. Cordonnier, O. Cabaret, 2012, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia.

O. Lortholary, C. Cordonnier, M. Tod, 2008, The Lancet. Infectious diseases.

Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients

P. Bierling, J. Bernaudin, C. Cordonnier, 1986, Cancer.

Sjögren syndrome: an unexpected disease occurring fourteen years after oligoarticular onset juvenile idiopathic arthritis.

A. Prieur, S. Testelin, M. Alyanakian, 2002, Rheumatology.

Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell transplant

H. Einsele, M. Labopin, K. Jansen, 2010, Bone Marrow Transplantation.

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

N. Russell, P. Ljungman, R. Martino, 2001, Bone Marrow Transplantation.

Re: "Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis" by Horita et al.

D. Livermore, T. Calandra, I. Gyssens, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients.

D. Livermore, C. Viscoli, M. Akova, 2014, The Journal of infection.

Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation.

C. Haioun, J. Bernaudin, D. Payen, 1985, The American review of respiratory disease.

Pulmonary veno-occlusive disease after bone marrow transplantation.

J. Bernaudin, X. Troussard, C. Cordonnier, 1984, Thorax.

Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor.

G. Chatellier, O. Meyer, C. Cordonnier, 1996, British journal of rheumatology.

Primary in vitro culture of porcine tracheal epithelial cells in an air-liquid interface as a model to study airway epithelium and Aspergillus fumigatus interactions.

É. Allaire, C. Cordonnier, O. Cabaret, 2010, Medical mycology.

Phagocytosis of Aspergillus fumigatus conidia by primary nasal epithelial cells in vitro

C. Cordonnier, E. Escudier, A. Coste, 2008, BMC Microbiology.

Aspergillus fumigatus causes in vitro electrophysiological and morphological modifications in human nasal epithelial cells.

C. Cordonnier, E. Escudier, A. Coste, 2002, Histology and histopathology.

Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation.

H. Einsele, R. Martino, C. Cordonnier, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The epidemiology of invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?

J. Donay, P. Legrand, C. Cordonnier, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.

H. Einsele, M. Labopin, D. Niederwieser, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pneumonia After Hematopoietic Stem Cell Transplantation

C. Cordonnier, 2016, Transplant Infections.

Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia.

M. Vidaud, S. Amselem, C. Cordonnier, 1990, Leukemia.

Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).

R. Porcher, M. Mohty, G. Socié, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes

J. Byrne, S. Mackinnon, A. Gratwohl, 2004, Bone Marrow Transplantation.

Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients.

C. Cordonnier, L. Hessel, M. Préziosi, 1992, The Journal of infectious diseases.

Clofarabine as a potential stimulant of alloreactivity

C. Cordonnier, C. Pautas, S. Maury, 2011, Bone Marrow Transplantation.

Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)

J. Esteve, C. Craddock, M. Labopin, 2015, Leukemia.

When to change treatment of acute invasive aspergillosis: an expert viewpoint

Yee-Chun Chen, F. Marty, J. Rex, 2021, The Journal of antimicrobial chemotherapy.

Eruption of lymphocyte recovery with atypical lymphocytes mimicking a primary cutaneous T-cell lymphoma: a series of 12 patients.

P. Wolkenstein, E. Sbidian, O. Chosidow, 2018, Human pathology.

Histiocytoid Sweet Syndrome Is More Frequently Associated With Myelodysplastic Syndromes Than the Classical Neutrophilic Variant

C. Haioun, P. Wolkenstein, O. Chosidow, 2016, Medicine.

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

N. Schmitz, D. Blaise, H. Greinix, 2003, Bone Marrow Transplantation.

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.

P. Fenaux, X. Thomas, X. Troussard, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.

H. Tilly, P. Fenaux, X. Troussard, 1993, Leukemia.

Autologous Stem Cell Transplantation in Acute Promyelocytic Leukemia Patients Achieving a Second Complete Remission

H. Dombret, A. Vekhoff, P. Fenaux, 2000 .

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.

P. Ljungman, C. Kibbler, C. Cordonnier, 2018, The Journal of antimicrobial chemotherapy.

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

H. Einsele, P. Hauser, W. Melchers, 2016, The Journal of antimicrobial chemotherapy.

Azole Resistance in Aspergillus fumigatus—Current Epidemiology and Future Perspectives

C. Cordonnier, S. Bretagne, A. Alanio, 2011 .

I11 Epidemiology and risk factors for serious infections in the stem cell transplant setting

C. Cordonnier, S. Maury, 2007 .

Management of infectious complications in hematological patients

C. Cordonnier, 2004 .

Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia

H. Dombret, H. Tilly, C. Bastard, 2005, Bone Marrow Transplantation.

Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.

E. Solary, H. Tilly, E. Wattel, 1999, Advances in experimental medicine and biology.

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

H. Einsele, R. Brand, A. Gratwohl, 2005, Bone Marrow Transplantation.

Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire.

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial.

J. Bourhis, H. Dombret, B. Quesnel, 2012, Leukemia research.

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.

M. Maris, R. Storb, B. Sandmaier, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive Therapy of Myelodysplastic Syndromes and Secondary Leukemias: Preliminary Findings of the French Experience

E. Solary, H. Tilly, E. Wattel, 1997 .

Acute promyelocytic leukemia in 57 previously untreated patients

P. Bierling, F. Reyes, H. Jouault, 1985, Cancer.

Liposomal amphotericin B (AmBisome®) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis

R. Ebrahimi, C. Cordonnier, M. Bresnik, 2007, Mycoses.

Sequential Chemotherapy with Mitoxantrone, Etoposide and Cytarabine for Previously Treated Acute Myeloid Leukemia: EMA 86 Regimen

P. Fenaux, X. Thomas, X. Troussard, 1996 .

Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission.

X. Troussard, V. Leblond, M. Leporrier, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Grading System Based on Severity of Infection to Predict Mortality in Allogeneic Stem Cell Transplant Recipients

S. Chevret, E. Gluckman, C. Cordonnier, 2006, Transplantation.

Growth factor‐associated graft‐versus‐host disease and mortality 10 years after allogeneic bone marrow transplantation

M. Labopin, M. Mohty, O. Ringdén, 2012, British journal of haematology.

Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial

V. Diehl, N. Schmitz, R. Marcus, 2004, Bone Marrow Transplantation.

European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL‐4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN

P. Ljungman, C. Cordonnier, D. Engelhard, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Posttransplantation Lymphoproliferative Disorder Mimicking a Nonspecific Lymphocytic Pleural Effusion in a Bone Marrow Transplant Recipient

C. Rieux, C. Cordonnier, D. Desvaux, 1999, Acta Cytologica.

Cytomegalovirus encephalitis occurring after bone marrow transplantation.

C. Marsault, C. Cordonnier, J. Vernant, 2009, Scandinavian journal of haematology.

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7).

P. Ljungman, C. Cordonnier, D. Engelhard, 2019, The Lancet. Infectious diseases.

Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.

P. Bierling, H. Ansart‐Pirenne, C. Cordonnier, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High diversity of non‐sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?

C. Cordonnier, O. Cabaret, S. Bretagne, 2015, Mycoses.

Venocclusive disease of the liver after allogeneic bone marrow transplantation in man.

D. Dhumeaux, C. Cordonnier, G. Marinello, 1988, International journal of radiation oncology, biology, physics.

PREDICTING THE COSTS OF ALLOGENEIC SIBLING STEM-CELL TRANSPLANTATION: RESULTS FROM A PROSPECTIVE, MULTICENTER, FRENCH STUDY

S. Chevret, F. Roudot-thoraval, I. Durand-zaleski, 2004, Transplantation.

Interstitial pneumonitis and venocclusive disease of the liver after bone marrow transplantation.

C. Cordonnier, P. Piedbois, V. Benk, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reflections on gut decontamination in hematology.

C. Cordonnier, A. Buzyn, C. Tancrède, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

High dose intravenous gammaglobulin and platelet transfusions in leukaemic HLA-immunized patients.

A. Pesce, P. Bierling, C. Cordonnier, 2009, Scandinavian journal of haematology.

Molecular Demonstration of a Pneumocystis Outbreak in Stem Cell Transplant Patients: Evidence for Transmission in the Daycare Center

C. Cordonnier, F. Botterel, C. Angebault, 2017, Front. Microbiol..

Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia.

P. Reinert, S. Lemerle, C. Cordonnier, 1995, Bone Marrow Transplantation.

HLA‐DR and ICAM‐1 Expression and Modulation in Epithelial Cells From Nasal Polyps

M. Gendron, C. Cordonnier, J. Papon, 2002, The Laryngoscope.

Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study

C. Cordonnier, S. Bastuji‐Garin, F. Botterel, 2011, Haematologica.

Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis

A. Glasmacher, A. Thiébaut, C. Cordonnier, 2006, Cancer.

Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.

P. Moreau, A. Delmer, C. Cordonnier, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

H. Einsele, C. Heussel, P. Ljungman, 2010, Haematologica.

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor.

C. Cordonnier, C. Hézode, J. Beaumont, 2014, Blood.

Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies.

P. Bierling, S. Lachance, C. Cordonnier, 1997, Transplantation.

Bronchoalveolar lavage in immunocompromised patients. Clinical and functional consequences.

L. Brochard, F. Lemaire, F. Lebargy, 1992, Chest.

Legionnaires' disease and hairy-cell leukemia. An unfortuitous association?

C. Brun-Buisson, C. Cordonnier, J. Farcet, 1984, Archives of internal medicine.

Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

C. Heussel, M. Vehreschild, C. Cordonnier, 2017, The Journal of antimicrobial chemotherapy.

Myeloid-Derived Suppressive Cells Belonging to the Leukemic Clone Account for Immunosuppression In CMML

E. Solary, W. Vainchenker, B. Quesnel, 2010 .

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study

J. Bourhis, H. Dombret, C. Preudhomme, 2008 .

Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii

M. Lê, C. Cordonnier, A. Hulin, 2017, The Journal of antimicrobial chemotherapy.

Prevention of nosocomial fungal infection: the French approach.

B. Lebeau, R. Grillot, F. Derouin, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party.

H. Einsele, A. Alberti, P. Ljungman, 1994, Bone marrow transplantation.

Hepatitis C virus infection and allogeneic bone marrow transplantation.

B. Roche, C. Cordonnier, M. Kuentz, 1994, Transplantation.

High levels of anti-cytoskeleton autoantibodies are frequently associated with chronic GVHD

C. Cordonnier, G. Dighiero, J. Vernant, 1987 .

Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases.

J. Roujeau, J. Revuz, O. Chosidow, 1992, Journal of the American Academy of Dermatology.

Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

H. Einsele, A. Bosi, P. Ljungman, 2003, Bone Marrow Transplantation.

Antifungal prophylaxis in haematology patients: the role of voriconazole.

C. Cordonnier, Y. Hicheri, G. Cook, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

ANTIPNEUMOCOCCAL SEROPROTECTION YEARS AFTER VACCINATION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS.

C. Cordonnier, C. Pautas, M. Bahuaud, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7).

P. Ljungman, C. Cordonnier, D. Engelhard, 2019, The Lancet. Infectious diseases.

Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial

M. Labopin, P. Ljungman, C. Cordonnier, 2015, Bone Marrow Transplantation.

Pneumococcal immunization in immunocompromised hosts: where do we stand?

C. Cordonnier, D. Engelhard, D. Averbuch, 2014, Expert review of vaccines.

Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial.

H. Einsele, M. Labopin, D. Niederwieser, 2010, Vaccine.

CHAPTER 10 Infections after HSCT

C. Cordonnier, 2008 .

Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT

H. Einsele, P. Ljungman, R. Martino, 2005, Bone Marrow Transplantation.

Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.

C. Cordonnier, J. Vernant, P. Aucouturier, 1987, Blood.

Failure of a CD18/anti-LFA1 monoclonal antibody infusion to prevent graft rejection in leukemic patients receiving T-depleted allogeneic bone marrow transplantation.

A. Bernard, C. Cordonnier, M. Kuentz, 1989, Transplantation.

Title : Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant

C. Solano, D. Vanness, C. Cordonnier, 2014 .

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

A. Thiébaut, U. Flückiger, C. Cordonnier, 2011, Bone Marrow Transplantation.

Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

H. Einsele, P. Ljungman, R. Martino, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.

N. Mahlaoui, Y. Bertrand, A. Thiébaut, 2012, The Journal of antimicrobial chemotherapy.

A retrospective series of gut aspergillosis in haematology patients.

A. Vekhoff, A. Thiébaut, O. Reman, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.

C. Cordonnier, S. Bastuji‐Garin, F. Botterel, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.

M. Robin, M. Mohty, N. Vey, 2008, International journal of antimicrobial agents.

Treatment with 5-azacytidin upregulates the expression of CD20 in CD20-negative B cell acute lymphoblastic leukemia: a case report.

C. Cordonnier, O. Wagner-Ballon, C. Pautas, 2013, Experimental hematology.

Calcineurin activity as a functional index of immunosuppression after allogeneic stem-cell transplantation1

R. Barouki, C. Cordonnier, C. Pautas, 2004, Transplantation.

New findings and key questions in hematopoietic stem cell transplantation.

C. Cordonnier, F. Botterel, S. Bretagne, 2005, Medical mycology.

Liposomal Nystatin in Patients with Invasive Aspergillosis Refractory to or Intolerant of Amphotericin B

R. Sylvester, P. Moreau, G. Samonis, 2004, Antimicrobial Agents and Chemotherapy.

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

C. Cordonnier, S. Bretagne, P. Ribaud, 2004, Bone Marrow Transplantation.

Acquired ciliary abnormalities of nasal mucosa in marrow recipients.

F. Ricolfi, C. Cordonnier, E. Escudier, 1996, Bone marrow transplantation.

Bronchoalveolar lavage during neutropenic episodes: diagnostic yield and cellular pattern.

L. Brochard, J. Bernaudin, C. Cordonnier, 1994, The European respiratory journal.

[Mycologic surveillance of the environment for preventive invasive aspergillosis. Proposals for standardization of the methodologies and implementation].

F. Derouin, C. Cordonnier, E. Chachaty, 2002, Presse medicale.

Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays?

C. Cordonnier, M. Mikulska, Malgorzata Mikulska, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[Acute mast cell leukemia disclosed by vasomotor flushing].

P. Gaulard, J. Roujeau, M. Tulliez, 1997, Annales de dermatologie et de venereologie.

Definitions of infectious diseases and complications after stem cell transplant

H. Einsele, E. Holler, P. Ljungman, 2002 .

Successful non-myeloablative allogeneic HLA-identical stem cell transplantation for CD4/CD56 positive acute leukemia.

H. Jouault, C. Cordonnier, C. Pautas, 2007, Transplantation.

Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process?

P. Gaulard, C. Cordonnier, D. Bories, 2011, European journal of haematology.

Cancer chemotherapy and acral erythema.

J. Roujeau, C. Cordonnier, S. Matheron, 1982, Annals of internal medicine.

Three major achievements of the Infections Disease Group

M. Paesmans, M. Bassetti, L. Pylkkanen, 2012 .

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

J. Perfect, S. Holland, J. Sobel, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Apropos of the case reported by M. Leporrier et al., on mixed nodular lymphoma associated with a deficiency of C1-esterase inhibitor].

B. Dreyfus, C. Cordonnier, M. Kuentz, 1981, Nouvelle revue francaise d'hematologie.

Influence of clinical status on the efficiency of stored platelet transfusion

C. Haioun, C. Cordonnier, M. Kuentz, 1994, British journal of haematology.

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.

C. Cordonnier, F. Botterel, S. Bretagne, 2011, The Journal of antimicrobial chemotherapy.

Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia.

P. Fenaux, E. Archimbaud, V. Leblond, 1991, Blood.

ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

H. Einsele, P. Hauser, W. Melchers, 2016, The Journal of antimicrobial chemotherapy.

Empirical antifungal therapy in neutropaenic cancer patients with persistent fever

T. Calandra, C. Cordonnier, O. Marchetti, 2007 .

Usefulness of genotyping with microsatellite markers to investigate hospital-acquired invasive aspergillosis.

C. Cordonnier, S. Bretagne, E. Bart-Delabesse, 1999, The Journal of hospital infection.

Fatal primary cutaneous aspergillosis in a bone marrow transplant recipient: nosocomial acquisition in a laminar-air flow room.

C. Cordonnier, S. Bretagne, M. Kuentz, 1997, The Journal of hospital infection.

Association between circulating DNA, serum (1->3)-β-D-glucan, and pulmonary fungal burden in Pneumocystis pneumonia.

C. Cordonnier, O. Cabaret, F. Botterel, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Correlation Between Pneumocystis jirovecii Mitochondrial Genotypes and High and Low Fungal Loads Assessed by Single Nucleotide Primer Extension Assay and Quantitative Real‐Time PCR

L. Millon, C. Cordonnier, O. Cabaret, 2015, Journal of Eukaryotic Microbiology.

Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR

M. Vidaud, C. Cordonnier, J. M. Costa, 1995, Journal of clinical microbiology.

Impact of previous aspergillosis on the outcome of bone marrow transplantation.

D. De Bacquer, D. Bacquer, H. Prentice, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Oxalic acid level in bronchoalveolar lavage fluid from patients with invasive pulmonary aspergillosis.

J. Bernaudin, C. Cordonnier, A. Astier, 1985, The American review of respiratory disease.

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

A. Vekhoff, L. Adès, C. Cordonnier, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Updated guidelines for managing fungal diseases in hematology patients

C. Cordonnier, C. Pautas, S. Maury, 2010, Expert review of anti-infective therapy.

Galactomannan and polymerase chain reaction for the diagnosis of primary digestive aspergillosis in a patient with acute myeloid leukaemia.

C. Cordonnier, J. M. Costa, S. Bretagne, 2001, The Journal of infection.

Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial

C. Brun-Buisson, I. Durand-zaleski, J. Pottecher, 2017, Intensive Care Medicine.

Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant

S. Sorensen, C. Solano, D. Vanness, 2017, Mycoses.

Empirical Versus Pre-Emptive Antifungal Therapy in High-Risk Febrile Neutropenic Patients: A Prospective Randomized Study.

A. Vekhoff, S. Leprêtre, L. Adès, 2006 .

Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients

H. Einsele, P. Ljungman, C. Cordonnier, 2011, Haematologica.

Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis.

H. Einsele, R. Brand, D. Niederwieser, 2003, Blood.

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

H. Einsele, P. Ljungman, L. Volin, 2002, Blood.

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

H. Einsele, T. Klingebiel, P. Ljungman, 2001, Blood.

Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.

H. Einsele, P. Ljungman, C. Cordonnier, 1993, Bone marrow transplantation.

Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group.

H. Tilg, P. Biron, P. Ljungman, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Commi

W. Wood, N. Kröger, M. Perales, 2020, Biology of Blood and Marrow Transplantation.

Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5).

T. Berg, P. Ljungman, H. Wedemeyer, 2016, The Lancet. Infectious diseases.

Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model

B. Farley, A. Vekhoff, S. Leprêtre, 2013, PloS one.

Evolution of bacterial susceptibility to antibiotics during a six-year period in a haematology unit.

J. Duval, R. Leclercq, C. Cordonnier, 1995, The Journal of hospital infection.

[Parsonage-Turner syndrome disclosing HIV seropositivity].

C. Cordonnier, J. Ziza, P. Chazerain, 1993, Annales de medecine interne.

Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation

H. Einsele, D. Navarro, P. Hubáček, 2019, Haematologica.

Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

E. Deconinck, R. Martino, C. Cordonnier, 2000, Bone Marrow Transplantation.

Vaccination of hematopoietic cell transplant recipients

H. Einsele, P. Ljungman, J. Englund, 2009, Bone Marrow Transplantation.

Regionally limited or rare infections: prevention after hematopoietic cell transplantation

H. Masur, J. Gea-Banacloche, T. Chiller, 2010, Bone Marrow Transplantation.

Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT)

H. Einsele, A. Bosi, H. Prentice, 1998, Bone Marrow Transplantation.

Evaluation of three assays on alveolar lavage fluid in the diagnosis of cytomegalovirus pneumonitis after bone marrow transplantation.

J. Bernaudin, J. Nicolas, C. Cordonnier, 1987, The Journal of infectious diseases.

European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

H. Einsele, P. Ljungman, C. Cordonnier, 1996, Bone marrow transplantation.

Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem‐cell transplant recipients

C. Cordonnier, S. Bretagne, J.-M. Costa, 2000, Transplant infectious disease : an official journal of the Transplantation Society.

Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.

H. Einsele, R. Brand, P. Ljungman, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7).

H. Einsele, D. Navarro, P. Hubáček, 2019, The Lancet. Infectious diseases.

Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy.

R. Leclercq, C. Cordonnier, A. Buzyn, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Should Immunoglobulin Therapy Be Used in Allogeneic Stem-Cell Transplantation?

S. Chevret, E. Gluckman, C. Cordonnier, 2003, Annals of Internal Medicine.

Real-Time PCR for Diagnosis and Follow-Up of Toxoplasma Reactivation after Allogeneic Stem Cell Transplantation Using Fluorescence Resonance Energy Transfer Hybridization Probes

C. Cordonnier, S. Bretagne, C. Pautas, 2000, Journal of Clinical Microbiology.

Septic hip arthritis after multiple injections into the joint of hyaluronate and glucocorticoid.

C. Cordonnier, J. Ziza, P. Chazerain, 1999, Revue du rhumatisme.

Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia Studies investigating combination therapy of a beta-lactam with an aminoglycoside in animals with neutropenia

D. Dale, C. Cordonnier, H. Reynolds, 2008 .

Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.

V. Leblond, C. Cordonnier, R. Herbrecht, 1995, Journal of chemotherapy.

The European Hematology Association Roadmap for European Hematology Research: a consensus document.

G. Salles, B. Coiffier, H. Döhner, 2016, Haematologica.

Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling.

F. Locatelli, A. Ghavamzadeh, Chi-kong Li, 2013, Blood.

Overcoming the Negative Impact of Age Using Fludarabine-Based Conditioning Regimens for HLA-Identical Sibling HSCT in Patients with Severe Aplastic Anemia (SAA): A Study from the EBMT-SAA Working Party.

D. Blaise, J. Passweg, A. Bacigalupo, 2006 .

Adult Acute Lymphoblastic Leukemia — Results of the French AALL 87 Protocol with Different Strategies of Postremission Therapy

H. Dombret, A. Delannoy, C. Sebban, 1994 .

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response.

H. Einsele, P. Hauser, W. Melchers, 2017, The Journal of antimicrobial chemotherapy.

Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.

P. Bruzzi, M. Ceppi, T. Calandra, 2018, The Journal of infection.

Acral erythema and systemic toxicity related to CHA induction therapy in acute myeloid leukemia.

É. Oksenhendler, J. Roujeau, P. Landais, 1989, European journal of cancer & clinical oncology.

Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation.

P. Jaksch, O. Witzke, F. Saliba, 2019, The New England journal of medicine.

Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases.

J. Roujeau, M. Bagot, C. Cordonnier, 1990, Journal of the American Academy of Dermatology.

Radiation-induced bone sarcoma following total body irradiation: role of additional radiation on localized areas

C. Rieux, C. Cordonnier, M. Kuentz, 2000, Bone Marrow Transplantation.

Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey

P. Ljungman, R. Martino, C. Cordonnier, 2002, British journal of haematology.

Serum IgG subclasses in secondary immunodeficiencies.

C. Cordonnier, L. Noël, P. Lesavre, 1988, Monographs in allergy.

Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines?

C. Cordonnier, F. Botterel, C. Pautas, 2018, Bone Marrow Transplantation.

Toxoplasmosis following allogeneic hematopoietic stem cell transplantation

R. Martino, C. Cordonnier, 2003, Bone Marrow Transplantation.

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, O. Ringdén, K. Le Blanc, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

P. Ljungman, C. Cordonnier, D. Engelhard, 2016, Haematologica.

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

H. Dombret, A. Stamatoullas, A. Vekhoff, 2000, Leukemia.

Additional total-lymphoid irradiation in preventing graft failure of T-cell-depleted bone marrow transplantation from HLA-identical siblings. Results of a prospective randomized study.

C. Cordonnier, M. Kuentz, J. Vernant, 1988, Transplantation.

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

H. Einsele, P. Ljungman, R. Martino, 2011, Haematologica.

Cost of allogeneic bone marrow transplantation in four diseases.

D. Jolly, C. Griscelli, C. Viens-Bitker, 1989, Health policy.

CHIMERISM ANALYSIS BY LINEAGE-SPECIFIC FLUORESCENT POLYMERASE CHAIN REACTION IN SECONDARY GRAFT FAILURE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

M. Tulliez, H. Jouault, C. Cordonnier, 2001, Transplantation.

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

S. Montoto, N. Kröger, S. Iacobelli, 2019, Bone Marrow Transplantation.

Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population

C. Cordonnier, D. Bories, K. Belhadj, 2001, Bone Marrow Transplantation.

Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO‐incompatible allogeneic haematopoietic stem cell transplantation

F. Noizat‐Pirenne, C. Cordonnier, C. Pautas, 2007, Vox sanguinis.

Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors

M. Maris, R. Storb, B. Sandmaier, 2006 .

Enhancement of alloimmunization: a potential hazard of GM‐CSF treatment in patients with severe aplastic anemia?

P. Bierling, C. Cordonnier, M. Kuentz, 1989, Transfusion.

Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation.

H. Einsele, P. Ljungman, C. Cordonnier, 1995, Bone marrow transplantation.

Le programme JACIE (Joint Accreditation Committee of ISCT-Europe and EBMT). Pourquoi ? Pour qui ?

H. Esperou, C. Cordonnier, C. Pautas, 2008 .

ABSENCE OF GRAFT‐VERSUS‐LEUKAEMIA (GVL) EFFECT BY LEUCOCYTES TRANSFUSED: A PROSPECTIVE RANDOMIZED TRIAL IN ACUTE MYELOID LEUKAEMIA (AML) PATIENTS

P. Bierling, C. Cordonnier, M. Kuentz, 1991, British journal of haematology.

[Calculation of direct standard costs in the evaluation of new technologies: application to the treatment of acute myeloblastic leukemias].

D. Jolly, C. Viens-Bitker, C. Cordonnier, 1986, Revue d'epidemiologie et de sante publique.

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

N. Schmitz, W. Friedrich, A. Gratwohl, 2002, Bone Marrow Transplantation.

Lymphadenopathy-associated virus/human T-lymphotropic virus type III in allogeneic bone marrow transplantation.

P. Bierling, C. Cordonnier, D. Mathez, 1986, Annals of internal medicine.

6: A Multicentric Comparative Analysis of Outcomes of HLA Identical Related Cord Blood and Bone Marrow Transplantation in Patients With Beta-Thalassemia or Sickle Cell Disease

A. Ghavamzadeh, Chi-kong Li, I. Roberts, 2008 .

Applying the concept of healthcare-associated infections to hematology programs.

J. Carlet, P. Legrand, C. Cordonnier, 2006, Haematologica.

Infection à cytomégalovirus

C. Cordonnier, B. Sénéchal, A. Fillet, 2000 .

The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party.

S. Montoto, R. Bouabdallah, M. Pfreundschuh, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Large granular lymphocytes in bronchoalveolar lavage fluids from immunocompromised patients with cytomegalovirus pneumonitis.

J. Bernaudin, C. Cordonnier, E. Escudier, 1986, American journal of clinical pathology.

Bacteremia due to Capnocytophaga species in patients with neutropenia: high frequency of beta-lactamase-producing strains.

T. Leblanc, P. Rousselot, P. Legrand, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.

D. Blaise, V. Leblond, C. Cordonnier, 1993, Bone marrow transplantation.

The mixed epidermal cell lymphocyte‐reaction is the most predictive factor of acute graft‐versus‐host disease in bone marrow graft recipients

J. Mary, J. Levy, M. Bagot, 1988, British journal of haematology.

Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia.

M. Tulliez, O. Chosidow, C. Cordonnier, 2013, Journal of the American Academy of Dermatology.

Low Dose Total Body Irradiation in Allogeneic Bone Marrow Transplantation for Hematological Malignancy: Incidence of Interstitial Pneumonitis and Relapse after Longterm Follow-Up

P. Bierling, B. Dreyfus, C. Cordonnier, 1985 .

therapy of cytomegalovirus infection after allogeneic stem cell transplantation Randomized multicenter trial of foscarnet versus ganciclovir for preemptive

H. Einsele, L. Volin, C. Cordonnier, 2013 .

Letermovir for secondary prophylaxis of CMV infection and disease after allogeneic hematopoietic cell transplantation: Results from the French compassionate program.

A. Thiébaut, C. Cordonnier, S. Alain, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients

I. Durand-zaleski, C. Cordonnier, F. Hemery, 2017, BMC Infectious Diseases.

Reporting infectious complications in haematology clinical trials should be improved.

P. Ljungman, C. Cordonnier, G. Maschmeyer, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

High levels of anti‐cytoskeleton autoantibodies are frequently associated with chronic GVHD

C. Cordonnier, G. Dighiero, J. Vernant, 1987, British journal of haematology.

Autologous Bone Marrow Transplantation with 10-Day-Cultured Bone Marrow Activated by Interleukin-2 in Two Patients with Acute Lymphoblastic Leukemia

S. Lemerle, C. Cordonnier, F. Bernaudin, 1992 .

Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation

M. Labopin, D. Blaise, J. Reiffers, 2003, Leukemia.

LONG-TERM IMMUNITY TO MEASLES AFTER ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION: FACTORS ASSOCIATED WITH SEROPROTECTION BEFORE REVACCINATION: Immunity to measles after HCT.

F. Rozenberg, C. Cordonnier, C. Pautas, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of Priming with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Younger Adults with Newly Diagnosed Acute Myeloid Leukemia (AML): A Trial by the Acute Leukemia French Association (ALFA) Group.

J. Bourhis, H. Dombret, B. Quesnel, 2005 .

Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party

J. Delgado, N. Kröger, S. Leprêtre, 2017 .

Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients

R. Bouabdallah, P. Cony-Makhoul, A. Delannoy, 1997, Leukemia.

Bronchoalveolar llavage dduring nneutropenic eepisodes: diagnostic yyield aand ccellular ppattern

L. Brochard, C. Cordonnier, E. Escudier, 1994 .

Erratum: Regionally limited or rare infections: Prevention after hematopoietic cell transplantation (Bone Marrow Transplantation (2009) 44 (489-494) DOI: 10.1038/bmt.2009.260)

H. Masur, J. Gea-Banacloche, T. Chiller, 2010 .

Aspergillosis prior to bone marrow transplantation. Infectious Diseases Working Party of the EBMT and the EORTC Invasive Fungal Infections Cooperative Group.

P. Ljungman, C. Cordonnier, F. Meunier, 1995, Bone marrow transplantation.

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

F. Jardin, T. Petrella, E. Macintyre, 2019, Blood advances.

Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study

N. Schmitz, N. Kröger, S. Iacobelli, 2016, Annals of Hematology.

Emergence of MPLW515 mutation in a patient with CALR deletion: Evidence of secondary acquisition of MPL mutation in the CALR clone

M. Tulliez, C. Cordonnier, S. Giraudier, 2018, Hematological oncology.

Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT

S. Montoto, N. Kröger, P. Chevallier, 2019, Bone Marrow Transplantation.

Risk Factors and Scoring System for Predicting Bacterial Resistance to Cefepime as Used Empirically in Haematology Wards

P. Legrand, C. Cordonnier, C. Pautas, 2015, BioMed research international.

Treatment for Acute Myelogenous Leukemia by Low Dose Irradiation Based Conditioning and Hematopoietic Cell Transplantation from Related and Unrelated Donors.

M. Maris, R. Storb, B. Sandmaier, 2004 .

Epidemiology of S pneumoniae Infection in Hematology Patients in Ile de France: Serotypes Covered by the Polysaccharide 23-Valent (PS23) and the Heltavalent Conjugate Vaccine.

J. Donay, P. Legrand, C. Cordonnier, 2007 .

Synthesis of new fundamental heterocycles. Part VII. Synthesis of 2‐azaxanthene

C. Cordonnier, H. Sliwa, 1977 .

HLA-DR restriction in suppression of hematopoiesis by T cells from allogeneic bone marrow transplants.

W. Vainchenker, C. Cordonnier, J. Vernant, 1986, Journal of immunology.

A POSSIBLE PREDICTIVE TEST FOR GRAFT‐VERSUS‐HOST DISEASE IN BONE MARROW GRAFT RECIPIENTS: THE MIXED EPIDERMAL CELL‐LYMPHOCYTE REACTION

L. Dubertret, J. Levy, M. Bagot, 1986, Transplantation.

2017 ECIL 7 vaccine guidelines.

P. Ljungman, C. Cordonnier, S. Cesaro, 2019, The Lancet. Infectious diseases.

Maribavir Versus Valganciclovir for Pre-Emptive Treatment of Cytomegalovirus Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant and Solid Organ Transplant Recipients

P. Jaksch, O. Witzke, F. Saliba, 2017 .

Maribavir Versus Valganciclovir for Preemptive Treatment of Cytomegalovirus (CMV) Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant (SCT) and Solid Organ Transplant (SOT) Recipients

P. Jaksch, O. Witzke, F. Saliba, 2016 .

Severity of illness scores: Are they useful in febrile neutropenic adult patients in hematology wards? A prospective multicenter study

B. Schlemmer, C. Cordonnier, S. Bastuji‐Garin, 2001, Critical care medicine.

Risk factors for Gram-negative bacterial infections in febrile neutropenia.

R. Leclercq, C. Cordonnier, A. Buzyn, 2005, Haematologica.

[Bacterial septicemia in neutropenia patients].

J. Duval, B. Dreyfus, C. Cordonnier, 1983, Annales de medecine interne.

How many plasma exchanges to cure thrombotic thrombocytopenic purpura?

C. Cordonnier, J. Vernant, A. Sobel, 2009, Scandinavian journal of haematology.

RECONSTITUTION OF CYTOTOXIC T LYMPHOCYTE ACTIVITY: Following Allogeneic Bone Marrow Transplantation In Man

J. Levy, M. Bagot, C. Cordonnier, 1987, Transplantation.

A new workflow for the microbiological diagnosis of febrile neutropenia in patients with a central venous catheter.

E. Sbidian, C. Cordonnier, S. Bastuji‐Garin, 2013, The Journal of antimicrobial chemotherapy.

Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia

J. Bernaudin, C. Cordonnier, F. Lange, 1983, Cancer.

Late toxoplasmosis evidenced by PCR in a marrow transplant recipient.

M. Vidaud, C. Cordonnier, J. M. Costa, 1995, Bone marrow transplantation.

[Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia].

C. Cordonnier, G. Andreu, M. Monconduit, 1994, Nouvelle revue francaise d'hematologie.

Clinical Significance of Quantifying Pneumocystis jirovecii DNA by Using Real-Time PCR in Bronchoalveolar Lavage Fluid from Immunocompromised Patients

C. Cordonnier, O. Cabaret, F. Botterel, 2011, Journal of Clinical Microbiology.

Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administration

C. Cordonnier, S. Bastuji‐Garin, C. Pautas, 2016, American journal of hematology.

Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2009 .

Toxoplasmosis as an early complication of allogeneic hematopoietic cell transplantation.

C. Cordonnier, F. Botterel, C. Angebault, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer

C. Schaefer-Prokop, F. Baron, M. Paesmans, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

G. Papanicolaou, B. Alexander, Deepali Kumar, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fungal infections: current diagnosis and treatment.

C. Cordonnier, 2004, The hematology journal : the official journal of the European Haematology Association.

Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.

D. Livermore, I. Gyssens, C. Viscoli, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in allogeneic hematopoietic cell transplant recipients (PNEU-STEM).

P. Ljungman, R. Dagan, C. Cordonnier, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The first European conference on infections in leukaemia: Why and how?

T. Calandra, C. Cordonnier, 2007 .

Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review.

Ibrahim N. Muhsen, M. Aljurf, J. Szer, 2023, The Lancet. Haematology.

Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review.

Ibrahim N. Muhsen, M. Aljurf, J. Szer, 2023, The Lancet. Haematology.

Immune Response to the 23-Valent Polysaccharide Pneumococcal Vaccine (PPV23) after the 7-Valent Conjugate Vaccine (PCV7) in Allogeneic Stem Cell Transplant (SCT) Recipients: Results of the EBMT IDWP01 Trial

H. Einsele, M. Labopin, D. Niederwieser, 2008 .

Quality control for the diagnosis of Toxoplasma gondii reactivation in SCT patients using PCR assays

R. Martino, C. Cordonnier, D. Krüger, 2001, Bone Marrow Transplantation.

Case 52-1982: legionnaires' disease complicating hairy-cell leukemia.

C. Cordonnier, J. Farcet, A. Bure, 1983, The New England journal of medicine.

Is Early Response to Chemotherapy a Useful Prognostic Factor in Adult Acute Lymphoblastic Leukemia

C. Sebban, É. Lepage, X. Troussard, 1994 .

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

H. Einsele, P. Hauser, W. Melchers, 2016, The Journal of antimicrobial chemotherapy.

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

J. Perfect, S. Holland, J. Sobel, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

J. S. Daly, A. Casadevall, I. Sia, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Regionally limited or rare infections: prevention after hematopoietic cell transplantation

H. Masur, C. Cordonnier, M. Tomblyn, 2009, Bone Marrow Transplantation.

Human herpesvirus 6 infection in patients with exanthema after allogeneic bone marrow transplantation.

H. Agut, O. Chosidow, C. Cordonnier, 1998, Archives of dermatology.

O. Lortholary, C. Cordonnier, S. Bastuji‐Garin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.

N. Mahlaoui, Y. Bertrand, A. Thiébaut, 2012, The Journal of antimicrobial chemotherapy.

Association between circulating DNA, serum (1->3)-β-D-glucan, and pulmonary fungal burden in Pneumocystis pneumonia.

C. Cordonnier, O. Cabaret, F. Botterel, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Updated guidelines for managing fungal diseases in hematology patients

C. Cordonnier, C. Pautas, S. Maury, 2010, Expert review of anti-infective therapy.

Pneumococcal immunization in immunocompromised hosts: where do we stand?

C. Cordonnier, D. Engelhard, D. Averbuch, 2014, Expert review of vaccines.

IgG subclass deficiency in acute myeloid leukemia.

C. Cordonnier, F. Guilhot, P. Aucouturier, 1989, Nouvelle revue francaise d'hematologie.

Questioning the Salicylates and Influenza Pandemic Mortality Hypothesis in 1918-1919

C. Cordonnier, C. Mondor, 2010 .

Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)

H. Einsele, L. Pagano, D. Navarro, 2023, Leukemia.

PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma.

E. Itti, C. Cordonnier, D. Bories, 2006, Haematologica.